ArticleBMJ health & care informatics2026
Early detection of female-specific cancers using longitudinal healthcare records with a multichannel convolutional neural network.
Article in BMJ health & care informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesFemale-specific cancers, including breast, ovarian, cervical and uterine malignancies, lack comprehensive early detection approaches, particularly for ovarian and endometrial cancers where effective population-level screening remains limited. This study aimed to develop and validate a computational method for early detection of female-specific cancers using longitudinal healthcare records.
methodsWe developed a multichannel convolutional neural network (MCNN) to analyse 36-month pre-diagnostic healthcare records from Taiwan's National Health Insurance Research Database. The study included 19 954 female patients (596 cancer cases, 19 358 controls) from 1999 to 2013. Log-likelihood ratio feature selection identified top 10 features across three data modalities (diagnostic codes, medications, medical orders). The six-channel architecture processed temporal patterns through stratified 10-fold cross-validation, with performance compared against nine baseline algorithms.
resultsMCNN achieved superior balanced performance with Macro-F₁ score of 0.8443, precision of 0.9135 and recall of 0.7978, outperforming traditional machine learning and deep learning approaches. Feature analysis revealed clinically relevant patterns including tamoxifen therapy, immunohistochemical procedures and cancer-specific diagnostic codes. SHapley Additive exPlanations (SHAP) interpretability analysis demonstrated the model's ability to identify pre-diagnostic phases through temporal healthcare utilisation patterns. Systematic feature selection reduced computational requirements by over 99%, enabling validation on Taiwan's population-scale National Health Insurance Research Database (NHIRD). DISCUSSION: The multichannel deep learning approach enables unified early detection across four female cancer types using routine administrative data, addressing detection gaps for ovarian and endometrial cancers while providing complementary risk stratification for existing screening programmes.
conclusionClinical implementation through electronic health record (EHR) integration offers practical pathways for accessible cancer risk assessment during routine healthcare encounters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.